NEW YORK (GenomeWeb News) - Fluidigm today filed a preliminary prospectus with the US Securities and Exchange Commission for a proposed initial public offering.

The filing revives the company's plans for an IPO after withdrawing an initial registration in 2008. At the time, the company hoped to raise up to $85 million, but abandoned the plan in September of that year amid the unfolding economic crisis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.

A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.

The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.

Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.